Run the damn trial competently.
The competition is racing right on by. Where are the new recruitment sites (5) promised in 2014 for early 2015? Not a word about them. UCSD hasn't recruited a single patient even though they are a trial site.
NSCLC is now going to be at least one year behind schedule. But hey, we have 30 million in the bank. Doesn't matter where this is listed, with execution like this the MC wouldn't change anyway.
"What we also have to consider is that (thus far) no big pharma has shown any interest is ddRNAi as a tecchnology. This could mean that any interest in our pipeline will be program specific, that is, if a particular target disease falls within the profile of the interested party. The real key here is for the Benitec to be able to structure one or more deals in the pre-clinial stage which have milestones that cover big pharmas risk. To date, Benitec has been particularly inept at doing so when compared to its peers."
Particularly inept!
Why don't you ask Panno the same question?
If you honestly think everything is just fine, then that is your prerogative. I simply can't abide the tech we have getting it's doors blown off by lesser competition that is able to execute and move forward.
- Forums
- ASX - By Stock
- Panno thoughts
Run the damn trial competently. The competition is racing right...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online